Biology Reference
In-Depth Information
Bountogo, M., Zoungrana, A., Coulibaly, B., Klose, C., Mansmann, U., Mockenhaupt, F.P.,
et al., 2010. Efficacy of methylene blue monotherapy in semi-immune adults with
uncomplicated falciparum malaria: a controlled trial in Burkina Faso. Trop. Med. Int.
Health: TM & IH 15 (6), 713-717.
Breman, J.G., de Quadros, C.A., Dowdle, W.R., Foege, W.H., Henderson, D.A., John, T.J.,
et al., 2011. The role of research in viral disease eradication and elimination programs:
lessons for malaria eradication. PLoS Med. 8 (1), e1000405.
Brooke, B.D., Hunt, R.H., Chandre, F., Carnevale, P., Coetzee, M., 2002. Stable
chromosomal inversion polymorphisms and insecticide resistance in the malaria
vector mosquito
Anopheles gambiae
(Diptera: Culicidae). J. Med. Entomol. 39 (4),
568-573.
Brown, P.J., 1998. Failure-as-success: multiple meanings of eradication in the Rockerfeller
Foundation Sardinia project, 1946-1951. Parassitologia 40, 117-130.
Bruce-Chwatt, L.J., Bruce-Chwatt, J.M., 1974. Malaria in Mauritius-as dead as the dodo.
Bull. N. Y. Acad. Med. 50 (10), 1069-1080.
Bruce-Chwatt, L.J., 1972. The role of drugs in a malaria program. Am. J. Trop. Med. Hyg.
21 (5), 731-735.
Bruce-Chwatt, L.J., 1977. Malaria eradication in Portugal. Trans. R. Soc. Trop. Med. Hyg.
71 (3), 232-240.
Cappellini, M.D., Fiorelli, G., 2008. Glucose-6-phosphate dehydrogenase deficiency. Lancet
371, 64-74.
Chanda, E., Hemingway, J., Kleinschmidt, I., Rehman, A.M., Ramdeen, V., Phiri, F.N., et al.,
2011. Insecticide resistance and the future of malaria control in Zambia. PloS One 6
(9), e24336.
Chen, W.I., 1991. Malaria eradication in Taiwan, 1952-1964-some memorable facts. Gaox-
iong Yi Xue Ke Xue Za Zhi (The Kaohsiung Journal of Medical Sciences) 7 (5),
263-270.
Choi, Y.K., Choi, K.M., Park, M.H., Lee, E.G., Kim, Y.J., Lee, B.C., et al., 2010. Rapid dis-
semination of newly introduced
Plasmodium vivax
genotypes in South Korea. Am. J. Trop.
Med. Hyg. 82 (3), 426-432.
Clark, H., Komp, W., Jobbins, D., 1942. A tenth year's observations on malaria in Panama,
with reference to the occurrence of variations in the parasite index, during continued
treatment with atabrine and plasmochine. Am. J. Trop. Med. 22, 191-216.
Clayman, C.B., Arnold, J., Hockwald, R.S.,Yount Jr., E.H., Edgcomb, J.H., Alving, A.S., 1952.
Toxicity of primaquine in Caucasians. J. Am. Med. Assoc. 149 (17), 1563-1568.
Clyde, D.F., 1962. Mass administration of an antimalarial drug combining 4-aminoquinoline
and 8-aminoquinoline in Tanganyika. Bull. World Health Organ. 27, 203-212.
Coatney, G.R., Alving, A.S., Jones Jr., R., Hankey, D.D., Robinson, D.H., Garrison, P.L., et al.,
1953. Korean vivax malaria.V. Cure of the infection by primaquine administered during
long-term latency. Am. J. Trop. Med. Hyg. 2 (6), 985-988.
Colbourne, M.J., 1962. Prospects for malaria eradication, with special reference to the West-
ern Pacific. Trans. R. Soc. Trop. Med. Hyg. 56, 179-201.
Coulibaly, B., Zoungrana, A., Mockenhaupt, F.P., Schirmer, R.H., Klose, C., Mansmann, U.,
et al., 2009. Strong gametocytocidal effect of methylene blue-based combination ther-
apy against falciparum malaria: a randomised controlled trial. PloS One 4 (5), e5318.
Crichlow, N., 1929. The prevalent diseases of the British Solomon Islands. Trans. R. Soc. Trop.
Med. Hyg. 23 (2), 179-184.
Cui, L.,Yan, G., Sattabongkot, J., Chen, B., Cao,Y., Fan, Q., et al., 2011. Challenges and pros-
pects for malaria elimination in the greater Mekong Subregion. Acta. Trop.
Culleton, R., Ndounga, M., Zeyrek, F.Y., Coban, C., Casimiro, P.N., Takeo, S., et al., 2009.
Evidence for the transmission of
Plasmodium vivax
in the Republic of the Congo, West
Central Africa. J. Infect. Dis. 200 (9), 1465-1469.
